154 related articles for article (PubMed ID: 1626554)
1. The end-stage renal disease program: trends over the past 18 years.
Port FK
Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):3-7. PubMed ID: 1626554
[TBL] [Abstract][Full Text] [Related]
2. Treatment modality patterns and transplantation among the United States pediatric end-stage renal disease population: a longitudinal study.
Held PJ; Turenne MN; Liska DW; Zobel DL; Webb RL; Alexander SR; Jones C
Clin Transpl; 1991; ():71-85. PubMed ID: 1820148
[TBL] [Abstract][Full Text] [Related]
3. End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions.
Port FK
Kidney Int Suppl; 1995 Aug; 50():S3-6. PubMed ID: 8544432
[TBL] [Abstract][Full Text] [Related]
4. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
5. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
6. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
Wong CF; McCarthy M; Howse ML; Williams PS
Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
[TBL] [Abstract][Full Text] [Related]
8. Impact of reimbursement regulations on patient management.
Hull AR
Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):8-11. PubMed ID: 1626555
[TBL] [Abstract][Full Text] [Related]
9. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
10. Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.
Friedlander MA; Hricik DE
Semin Nephrol; 1997 Jul; 17(4):331-45. PubMed ID: 9241718
[TBL] [Abstract][Full Text] [Related]
11. A report of the Malaysian dialysis registry of the National Renal Registry, Malaysia.
Lim YN; Lim TO; Lee DG; Wong HS; Ong LM; Shaariah W; Rozina G; Morad Z
Med J Malaysia; 2008 Sep; 63 Suppl C():5-8. PubMed ID: 19230240
[TBL] [Abstract][Full Text] [Related]
12. [Substitutes for renal function. Technical trends and logistics of treatment].
Legrain M; Rottembourg J
C R Seances Soc Biol Fil; 1981; 175(5):669-93. PubMed ID: 6456794
[TBL] [Abstract][Full Text] [Related]
13. [Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].
Canaud B; Mion C
Nephrologie; 1995; 16(1):129-35. PubMed ID: 7700413
[TBL] [Abstract][Full Text] [Related]
14. [Peritoneal dialysis in the aged].
Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N
Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386
[TBL] [Abstract][Full Text] [Related]
15. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.
Hattori S; Yosioka K; Honda M; Ito H;
Pediatr Nephrol; 2002 Jun; 17(6):456-61. PubMed ID: 12107812
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
[TBL] [Abstract][Full Text] [Related]
17. Dialysis therapy among elderly patients; data from the Canadian Organ Replacement Register, 1981-1991.
Fenton SS; Desmeules M; Jeffery JR; Corman JL
Adv Perit Dial; 1993; 9():124-9. PubMed ID: 8105905
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001.
Guo H; Kalra PA; Gilbertson DT; Liu J; Chen SC; Collins AJ; Foley RN
Circulation; 2007 Jan; 115(1):50-8. PubMed ID: 17179020
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of end stage renal disease and implications for public policy.
Rubin RJ
Public Health Rep; 1984; 99(5):492-8. PubMed ID: 6435162
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
